Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-Mi-2 antibodies.

Anna Ghirardello1, Sandra Zampieri, Luca Iaccarino

  • 1Division of Rheumatology, Medical Clinics, Department of Medical and Surgical Sciences, University of Padova, Italy.

Autoimmunity
|June 22, 2005
PubMed
Summary

Autoantibodies against the Mi-2 nuclear antigen are key markers for idiopathic inflammatory myopathies, particularly dermatomyositis. Testing via ELISA and immunoblot confirms their presence and aids in diagnosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do DMARDs increase the risk of cancer recurrence in patients with spondyloarthritis, psoriatic arthritis and rheumatoid arthritis?

Clinical and experimental rheumatology·2026
Same author

Comparative real-world effectiveness and safety of benralizumab and two mepolizumab dosing regimens in eosinophilic granulomatosis with polyangiitis: a 24-month prospective single-center cohort study.

Frontiers in immunology·2026
Same author

Switching from intravenous to subcutaneous infliximab in Behçet's disease: feasibility, safety and early outcomes.

Clinical and experimental rheumatology·2026
Same author

Advancing Care in Lupus Nephritis: Expert Perspectives on Current Practices and Future Directions in Italy.

Journal of clinical medicine·2026
Same author

Early belimumab accelerates renal response and reduces glucocorticoid exposure in lupus nephritis: a multicentre propensity-matched study.

Rheumatology (Oxford, England)·2026
Same author

Clinical and serological features of triple autoantibody-negative patients with systemic sclerosis: insights from the multicentric SPRING registry of the Italian Society for Rheumatology.

RMD open·2026

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • Autoantibodies targeting nuclear antigens are crucial diagnostic markers in autoimmune diseases.
  • The Mi-2 nuclear antigen is a component of the nucleosome remodeling-deacetylase (NuRD) complex, vital for gene transcription regulation.

Observation:

  • Anti-Mi-2 antibodies exhibit high specificity (98-100%) for idiopathic inflammatory myopathies.
  • These antibodies are found in 4-18% of patients with idiopathic inflammatory myopathies.
  • A significant association exists between anti-Mi-2 antibodies and dermatomyositis, present in up to 31% of cases.

Findings:

  • Anti-Mi-2 antibodies have a very high positive predictive value for dermatomyositis.
  • A strong correlation between anti-Mi-2 antibodies and the HLA-DR7 genotype has been observed.

Related Experiment Videos

  • Enzyme-linked immunosorbent assay (ELISA) screening on recombinant Mi-2 antigen, followed by immunoblot confirmation, represents the optimal serologic testing method.

    • Implications:

    • Detection of anti-Mi-2 antibodies aids in the specific diagnosis and subtyping of idiopathic inflammatory myopathies.
    • Understanding the role of the Mi-2 antigen in the NuRD complex may offer insights into disease pathogenesis.
    • Serologic markers like anti-Mi-2 antibodies are essential for accurate patient stratification and management in rheumatology.